Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression.
MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.
Personality disorders and dimensions in pathological gambling.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.
MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis. Brain. 2020 01 01; 143(1):55-68.
View in:
PubMed
subject areas
Abnormalities, Multiple
Adolescent
Basilar Artery
Carotid Arteries
Cerebellar Vermis
Cerebellum
Child
Child, Preschool
Cohort Studies
Comparative Genomic Hybridization
Craniofacial Abnormalities
Female
Fibroblasts
Humans
Imaging, Three-Dimensional
Infant
Intellectual Disability
Language Development Disorders
Magnetic Resonance Imaging
Male
Middle Aged
Mutation
Nervous System Malformations
Nonsense Mediated mRNA Decay
Polymicrogyria
Real-Time Polymerase Chain Reaction
Syndrome
Tomography, X-Ray Computed
Trans-Activators
Tumor Suppressor Proteins
Whole Genome Sequencing
authors with profiles
Russell Reid
William B. Dobyns